Analyst Robert Burns of H.C. Wainwright reiterated a Buy rating on Black Diamond Therapeutics (BDTX – Research Report), retaining the ...
EPS: CA$0.12 (down from CA$0.23 in 3Q 2023). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed ...
The 555.55 carat black diamond has belonged to its current owner for two decades but little is known about its history before that. A billion-year-old black diamond, believed to be the largest cut ...
CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Black Diamond Therapeutics, Inc. (BDTX) on Tuesday reported a loss of $15.6 million in its third quarter. The Cambridge, Massachusetts-based company ...